Ginkgo Bioworks Holdings annual operating income
2019
2020
2021
2022
2023
2024
2025
Ginkgo Bioworks Holdings Operating Income Growth & History (DNA)
Ginkgo Bioworks Holdings's operating income was −$315.3M for fiscal 2025.
View full Ginkgo Bioworks Holdings company overviewGinkgo Bioworks Holdings annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$315.3M | $244.5M | — |
| 2024 | 2024-12-31 | −$559.8M | $304.6M | — |
| 2023 | 2023-12-31 | −$864.4M | $1.34B | — |
| 2022 | 2022-12-31 | −$2.21B | −$380.5M | — |
| 2021 | 2021-12-31 | −$1.83B | −$1.69B | — |
| 2020 | 2020-12-31 | −$137.0M | −$65.4M | — |
| 2019 | 2019-12-31 | −$71.6M | — | — |
Ginkgo Bioworks Holdings quarterly operating income
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$58.5M | −$385,000 | — |
| Q1 2026 | 2026-03-31 | −$71.4M | $9.6M | — |
| Q4 2025 | 2025-12-31 | −$86.1M | $17.5M | — |
| Q3 2025 | 2025-09-30 | −$90.0M | −$34.8M | — |
| Q2 2025 | 2025-06-30 | −$58.2M | $164.8M | — |
| Q1 2025 | 2025-03-31 | −$81.0M | $97.0M | — |
| Q4 2024 | 2024-12-31 | −$103.6M | $74.5M | — |
| Q3 2024 | 2024-09-30 | −$55.2M | $231.2M | — |
| Q2 2024 | 2024-06-30 | −$222.9M | −$38.8M | — |
| Q1 2024 | 2024-03-31 | −$178.0M | $37.7M | — |
| Q4 2023 | 2023-12-31 | −$178.1M | $52.7M | — |
| Q3 2023 | 2023-09-30 | −$286.4M | $368.5M | — |
| Q2 2023 | 2023-06-30 | −$184.2M | $463.6M | — |
| Q1 2023 | 2023-03-31 | −$215.7M | $459.6M | — |
| Q4 2022 | 2022-12-31 | −$230.9M | $1.45B | — |
| Q3 2022 | 2022-09-30 | −$654.9M | −$628.3M | — |
| Q2 2022 | 2022-06-30 | −$647.8M | −$587.8M | — |
| Q1 2022 | 2022-03-31 | −$675.4M | −$618.3M | — |
| Q4 2021 | 2021-12-31 | −$1.68B | — | — |
| Q3 2021 | 2021-09-30 | −$26.7M | $7.7M | — |
| Q2 2021 | 2021-06-30 | −$59.9M | — | — |
| Q1 2021 | 2021-03-31 | −$57.1M | — | — |
| Q3 2020 | 2020-09-30 | −$34.4M | — | — |
Ginkgo Bioworks Holdings operating income trends
Over the last five fiscal years, Ginkgo Bioworks Holdings's operating income decreased from −$137.0M to −$315.3M, a change of −$178.3M. The latest reported quarter, Q2 2026, shows −$58.5M.
About the metric
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
Calculation and source
SEC-reported operating income
TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ginkgo Bioworks Holdings source filings ↗Community posts
Ginkgo joins a federally backed RNA-manufacturing project worth up to $17.5 million
Ginkgo Bioworks ($DNA) received a subcontract worth up to $17.5 million to participate in an ARPA-H program focused on RNA manufacturing. Waterfall Scientific is the prime contractor. The project, called ESCALATOR, is intended to combine co ...